Gut & Microbiome
peppermint oil treats irritable bowel syndrome
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Enteric-coated peppermint oil reduces global IBS symptoms and abdominal pain.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Khanna R, MacDonald JK, Levesque BG 2014 · J Clin Gastroenterol | meta-analysis | supports | moderate | MA: enteric-coated peppermint oil superior to placebo for IBS symptom improvement |
| Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, Mullin GE 2019 · BMC Complement Altern Med | meta-analysis | supports | moderate | Pooled MA: peppermint oil improved IBS global symptoms and abdominal pain vs placebo |
| Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D 2020 · Gastroenterology | RCT | tested-null | high | Peppermint oil did NOT beat placebo on FDA/EMA primary responder endpoints (some secondary pain endpoints improved). |
| Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ, Ford AC 2022 · Aliment Pharmacol Ther | meta-analysis | supports | moderate | Enteric peppermint oil reduced global IBS symptoms and abdominal pain vs placebo. |
| Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC 2020 · Lancet Gastroenterol Hepatol | meta-analysis | supports | moderate | Network MA: peppermint oil ranked among efficacious traditional IBS therapies |
| Hirata M, Fornari Laurindo L, Dogani Rodrigues V, Cristina Castilho Caracio F, Valenti VE, Pereira ESBM, Haber Mellem R, Penteado Detregiachi CR, Dos Santos Bueno M, Guissoni Campos LM, Spilla CSG, Barbalho SM 2025 · Pharmaceuticals (Basel, Switzerland) | RCT | supports | moderate | Systematic review, 16 Mentha clinical trials (IBS, functional dyspepsia, FAP), Cochrane RoB tool. Most studies reported significant benefit on abdominal pain/discomfort; 2 of the included trials found no superior outcome vs comparator. |
| Vermeijden NK, van der Feen C, Groeneweg M, Hummel T, Zagers D, Bertrams-Maartens I, van Wering H, Hurkmans P, Stapelbroek J, Sauvé I, Wessels M, Teklenburg-Roord S, Pruijsen-Nienhuis JM, Theuns-Valks SDM, Plomp TC, Bunkers C, Keszthelyi D, Benninga MA, Vlieger AM 2026 · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | RCT | contradicts | high | Dutch multicenter RCT, n=228 children 8-18y. Treatment success (>=30% pain reduction): peppermint oil 44.0% vs placebo 37.3% (OR 1.33, 97.5% CI 0.58-3.09, P=.44). Not superior to placebo. |
| Zeraattalab-Motlagh S, Ranjbar M, Mohammadi H, Adibi P 2025 · Nutr Rev | meta-analysis | supports | low | Umbrella review of syntheses: 'A total of 175 trials in 58 meta-analyses were entered'; 'soluble fiber, peppermint oil, and aloe vera improved IBS symptoms' but 'mainly shown small effects and low to very low evidence certainty.' Re-passes peppermint MAs the vault counts. Review — zero weight. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.